TheWealthWeb

ITI Pharma and Healthcare Fund Regular IDCW

ITI Mutual FundEquity Scheme - Sectoral/ ThematicRegular · IDCWRisk: Very High risk

NAV ₹18.6207 on 13 November 2026

AMFI name: ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option · Scheme code 149269

1 year
+14.74%
3 years, a year
+18.32%
5 years, a year
+13.19%
Since launch, a year
+13.22%

IDCW option: returns are NAV changes and leave out payouts, so they understate what investors received. Risk ratios are not shown for payout options.

NAV performance, last year

Returns

To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.

PeriodThis fundNIFTY HEALTHCARE INDEX TRICategory median
1M+9.23%+8.67%+5.63%
6M+11.39%+12.84%+6.99%
1Y+14.74%+38.92%+2.83%
3Y+18.32%+28.05%+13.18%
5Y+13.19%-+10.85%

Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates.

Category median: the middle return among Regular plans (Growth option) in AMFI's “Equity Scheme - Sectoral/ Thematic” category, up to 174 funds with clean data. Ranks are under “Rank among peers”.

Rank among peers

Regular plans, Growth option, in AMFI's “Equity Scheme - Sectoral/ Thematic” category. Each rank counts only the peers that have that figure.

Compare with Top Peers
3-Year Return Rank
-of 8
+18.32%
N/A
Q1
Q2
Q3
Q4
1-Year Return Rank
-of 8
+14.74%
N/A
Q1
Q2
Q3
Q4
Sharpe (Risk-Adjusted)
-of 8
-
N/A
Q1
Q2
Q3
Q4
Highest 3-year returns in the categoryRegular plans · Growth option
RankScheme Name3Y Return1Y ReturnSharpeDirect TERAUM
#1
Nippon India Mutual Fund
+46.52%+60.64%1.071.06%₹1,100 Cr
#2
HDFC Mutual Fund
+33.64%+20.34%1.070.89%₹11,128 Cr
#3
HDFC Mutual Fund
+31.28%+31.60%1.761.03%₹3,128 Cr
#4
SBI Mutual Fund
+25.42%+26.07%1.470.76%₹5,565 Cr
#5
HDFC Mutual Fund
+24.77%+10.10%1.091.10%₹1,997 Cr
#6
Mirae Asset Mutual Fund
+24.42%+27.89%1.28-₹3,458 Cr
#7
UTI Mutual Fund
+23.89%+22.00%1.311.35%₹1,399 Cr
#8
ICICI Prudential Mutual Fund
+22.73%+10.29%0.952.08%₹3,926 Cr
#-
ITI Pharma and Healthcare FundCurrent Fund
ITI Mutual Fund
+18.32%+14.74%-0.89%₹266 Cr

Costs and fund facts

Expense ratio (stated maximum)
Direct 0.89% · Regular 2.59%
Exit load
If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50% Exit Load after completion of 3 months - NIL
Fund size (all plans)
₹266 CrAverage, quarter to September 2026
Benchmark
NIFTY HEALTHCARE INDEX TRI
Allotment date
8 November 2021Scheme document
Type
An open ended Equity scheme investing in Pharma and Healthcare
AMFI scheme code
149269

Fund managers (2)

  • Animesh Singh
  • Nilay Dalal

How each manager has done since taking over: fund manager scorecard.

Investment objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

From the scheme summary document filed with AMFI.

SIP calculator

A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.

IDCW option: values use the NAV only and leave out the payouts, so they understate what an investor received. The Growth option of this fund shows the full return.

Monthly SIP Amount₹10,000
Investment Horizon5 Years
Simulating monthly 1st from 15 Nov 2021 to 13 Nov 2026
Total Invested61 mos
₹6,10,000
Units: 49,270.257
Current Portfolio Value
₹9,17,447
At latest recorded NAV
Total Profit
+₹3,07,447
+50.4% absolute return
SIP XIRR
16.36%
Annualised, money-weighted
Wealth CompositionProfit is 50% of total invested capital
Invested: ₹6,10,000Profit Generated: ₹3,07,447
Same SIP in the benchmark (NIFTY HEALTHCARE INDEX TRI)Same dates & amounts
Scheme SIP Valuation
₹9,17,447
16.4% XIRR
Benchmark SIP Valuation
₹5,56,767
25.8% XIRR
Fund minus benchmark
+₹3,60,680
Over 61 monthly installments
SIP instalments are bought on the first NAV date of each month; values use the latest NAV we hold. Past returns are not a guide to future returns.

About this fund

ITI Pharma and Healthcare Fund Regular IDCW is a mutual fund scheme from ITI Mutual Fund, listed by AMFI under “Equity Scheme - Sectoral/ Thematic”. This page covers the Regular plan with the IDCW option. Its NAV was ₹18.6207 on 13 November 2026. Its NAV changed by 14.74% over 1 year, 18.32% a year over 3 years and 13.19% a year over 5 years. These figures leave out IDCW payouts, so they understate what investors received. Its benchmark, NIFTY HEALTHCARE INDEX TRI, returned 28.05% a year over 3 years. The fund house rates its risk as “Very High risk” on the SEBI riskometer. Its average assets under management were ₹266 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 2.59% a year for the Regular plan. Managed by Animesh Singh and Nilay Dalal. Its scheme summary document gives the allotment date as 8 November 2021.

Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.

Plans and options of this fund (4)

PlanOptionISINAMFI codeNAV
RegularThis pageIDCWINF00XX01BN1149269₹18.6213 Nov 2026
DirectGrowthINF00XX01BO9149268₹20.5613 Nov 2026
DirectIDCWINF00XX01BQ4149271₹20.5613 Nov 2026
RegularGrowthINF00XX01BL5149270₹18.6213 Nov 2026